Pomelo Care, founded in 2021, provides evidence-based virtual healthcare for women and children across the United States. Its platform covers fertility and preconception, pregnancy and postpartum, pediatric care, and midlife health, operating in all 50 states with 24/7 access. The company has achieved unicorn status with a valuation of $1.7 billion, having raised $92 million in Series C funding.
The platform is built on predictive analytics, data science, and machine learning. Clinical outcomes reported by Pomelo include a 37% reduction in preterm births, an average 6.8-day reduction in NICU stays, and a 12% decrease in emergency room costs among its patient population. The service currently covers 25 million lives and reports a patient satisfaction rating of 4.9 out of 5.
Pomelo Care operates at the intersection of healthcare delivery and technology, applying data-driven methods to maternal and pediatric care. The company's scope spans the full continuum of women's health - from family planning through postpartum recovery and into midlife - while also offering pediatric services, positioning it as a comprehensive virtual provider in these verticals.
